• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. investors

Category

investors

8 videos

Looking back at 2024 - part 1 of a fireside chat about Invizyne
investors
Looking back at 2024 - part 1 of a fireside chat about Invizyne January 02, 2025 · 129 views
Invizyne IPO comments by CEO Michael Heltzen
investors
Invizyne IPO comments by CEO Michael Heltzen November 11, 2024 · 439 views
Dr. Lalonde: From two years and 25 scientists to a few scientists for a few months
investors
Dr. Lalonde: From two years and 25 scientists to a few scientists for a few months August 08, 2024 · 124 views
Dr. Lalonde: Invizyne [...] helps the sustainability of this planet
investors
Dr. Lalonde: Invizyne [...] helps the sustainability of this planet August 08, 2024 · 261 views
Commercializing Invizyne’s cell-free platform - fireside chat
investors
Commercializing Invizyne’s cell-free platform - fireside chat July 30, 2024 · 203 views
Invizyne IPO - KOL Call with Dr. James J. Lalonde (July 17, 2024)
investors
Invizyne IPO - KOL Call with Dr. James J. Lalonde (July 17, 2024) July 22, 2024 · 234 views
Invizyne presented by Michael Heltzen & Tyler Korman
investors
Invizyne presented by Michael Heltzen & Tyler Korman July 01, 2024 · 785 views
Invizyne presented by Chris Marlett
investors
Invizyne presented by Chris Marlett June 13, 2024 · 339 views
  • Previous
  • 1
  • 2
  • 3

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use